Discussion| Volume 173, ISSUE 1, P34, January 2023


    Published:October 10, 2022DOI:
        Dr Brenessa Lindeman (Birmingham, AL): Most institutions do not have this large of a patient population with hereditary pheochromocytomas. In your cohort, you defined the percentage of patients that went on to require resection of the contralateral adrenal gland. The purpose of cortex-sparing surgery is to provide patients the opportunity to lead a steroid-free life if they require resection of the contralateral gland. Can you tell us the number of, and the rationale for, contralateral adrenalectomy from your data set?
        To read this article in full you will need to make a payment

        Purchase one-time access:

        Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
        One-time access price info
        • For academic or personal research use, select 'Academic and Personal'
        • For corporate R&D use, select 'Corporate R&D Professionals'


        Subscribe to Surgery
        Already a print subscriber? Claim online access
        Already an online subscriber? Sign in
        Institutional Access: Sign in to ScienceDirect